A conformation-dependent epitope in Addison's disease and other endocrinological autoimmune diseases maps to a carboxyl-terminal functional domain of human steroid 21-hydroxylase

Journal of Immunology

Volumn 162, Issue 4, 1999, Pages 2422-2426

  Nikoshkov, Andrej ^a,d   Falorni, Alberto ^b   Lajic, Svetlana ^a   Laureti, Stefano ^b   Wedell, Anna ^a   Lernmark, Åke ^c   Luthman, Holger ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF WASHINGTON   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE; MUTANT PROTEIN; STEROID 21 MONOOXYGENASE;

ADDISON DISEASE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIGEN BINDING; ARTICLE; AUTOIMMUNITY; BINDING COMPETITION; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; EPITOPE MAPPING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GRAVES DISEASE; HUMAN; IMMUNOPATHOGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; SEQUENCE ANALYSIS;

ADDISON DISEASE; AUTOIMMUNE DISEASES; BLOTTING, WESTERN; EPITOPE MAPPING; EPITOPES; EXONS; HUMANS; PEPTIDE FRAGMENTS; PRECIPITIN TESTS; PROTEIN CONFORMATION; SEQUENCE ANALYSIS, DNA; STEROID 21-HYDROXYLASE;

EID: 0033558097     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Casiano, C. A., and E. M. Tan. 1996. Recent developments in the understanding of antinuclear autoantibodies. Int. Arch. Allergy Immunol. 111:308.
2. Nikoshkov, A., S. Lajic, A. Wedell, M. Holst, and H. Luthman. 1997. Synergistic effect of partially inactivating mutations in steroid 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 82:194.
3. Nikoshkov, A., S. Lajic, A. Vlamis-Gardikas, L. Tranebjaerg, M. Holst, A. Wedell, and H. Luthman. 1998. Naturally occurring mutants of human P450c21 pinpoint residues important for enzyme activity and stability. J. Biol. Chem. 273:6163.
4. Bottazzo, G. F., I. Todd, R. Mirakian, A. Belfiore, and R. Pujol-Borrell. 1986. Organ-specific autoimmunity: a 1986 overview. Immunol. Rev. 94:137.
5. Winqvist, O., F. A. Karlsson, and O. Kämpe. 1992. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 339:1559.
6. Miller, W. L., and Y. Morel. 1989. The molecular genetics of 21-hydroxylase deficiency. Annu. Rev. Genet. 23:371.
7. New, M. I. 1994. 21-Hydroxylase deficiency congenital adrenal hyperplasia. J. Steroid Biochem. Mol. Biol. 48:15.
8. Song, Y. H., E. L. Connor, A. Muir, J. X. She, B. Zorovich, D. Derovanesian, and N. Maclaren. 1994. Autoantibody epitope mapping of the 21-hydroxylase antigen in autoimmune Addison's disease. J. Clin. Endocrinol. Metab. 78:1108.
9. Wedlock, N., T. Asawa, A. Baumann-Antczak, B. R. Smith, and J. Furmaniak. 1993. Autoimmune Addison's disease: analysis of autoantibody binding sites on human steroid 21-hydroxylase. FEBS Lett. 332:123.
10. Asawa, T., N. Wedlock, A. Baumann-Antczak, B. R. Smith, and J. Furmaniak. 1994. Naturally occurring mutations in human steroid 21-hydroxylase influence adrenal autoantibody binding. J. Clin. Endocrinol. Metab. 79:372.
11. Falorni, A., A. Nikosjkov, S. Laureti, E. Grenbäck, A. L. Hulting, G. Casucci, F. Santeusanio, P. Brunetti, H. Luthman, and Å. Lernmark. 1995. High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J. Clin. Endocrinol. Metab. 80:2752.
12. Falorni, A., M. Ackefors, C. Carlberg, T. Daniels, B. Persson, J. Robertson, and Å. Lernmark. 1996. Diagnostic sensitivity of immunodominant epitopes of glulamic acid decarboxylase (GAD65) autoantibodies epitopes in childhood IDDM. Diabetologia 39:1091.
13. Kim, J., M. Namchuck, T. Bugawan, Q. Fu, M. Jaffe, Y. Shi, H.-J. Aanstoot, C. W. Turck, H. Erlich, V. Lennon, and S. Baekkeskov. 1994. Higher autoantibody levels and recognition of a linear N-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J. Exp. Med. 180:595.
14. Falorni, A., S. Laureti, A. Nikoshkov, M. L. Picchio, B. Hallengren, C. L. Vandewalle, F. K. Gorus, B. D. Registry, C. Tortoioli, H. Luthman, P. Brunetti, and F. Santeusanio. 1997. 21-Hydroxytase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Clin. Exp. Immunol. 107:341.
15. Hsu, O. C., M. C. Hu, H. C. Cheng, J. C. Lu, and B. C. Chung. 1993. The N-terminal hydrophobic domain of P450c21 is required for membrane insertion and enzyme stability. J. Biol. Chem. 268:14682.
16. 3H] recombinant human ligands. J. Immunol. Methods 186:89.
17. Wedell, A., E. M. Ritzén, B. Haglund-Stengler, and H. Luthman. 1992. Steroid 21-hydroxylase deficiency: three new mutated alleles and establishment of phenotype-genotype relationships of common mutations. Proc. Natl. Acad. Sci. USA 89:7232.
18. Uibo, R., E. Aavik, P. Peterson, J. Perheentupa, S. Aranko, R. Pelkonen, and K. J. Krohn. 1994. Autoantibodies to cytochrome P450 enzymes P450scc. P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. J. Clin. Endocrinol. Metab. 78:323.
19. Furmaniak, J., S. Kominami, T. Asawa, N. Wedlock, J. Colls, and B. R. Smith. 1994. Autoimmune Addison's disease: evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiency. J. Clin. Endocrinol. Metab. 79: 1517.
20. Thomsen, M., P. Platz, O. Andersen, M. Christy, J. Lyngsoe, J. Nerup, K. Rasmussen, L. P. Ryder, L. Staub-Nielsen, and A. Svejgaard. 1975. MLC typing in juvenile diabetes and idiopathic Addison's disease. Transplant Proc. 22:125.
21. Hoedemaekers, A. C., P. J. van Breda Vriesman, and M. H. De Baets. 1997. Myasthenia gravis as a prototype autoimmune receptor disease. Immunol. Res. 16:341.
22. Tassignon, J., F. Haeseleer, and A. Borkowski. 1997. Natural antiestrogen receptor autoantibodies in man with estrogenic activity in mammary carcinoma cell culture: study of their mechanism of action: evidence for involvement of estrogen-like epitopes. J. Clin. Endocrinol. Metab. 82:3464.
23. Callahan, L. N., G. Roderiquez, M. Mallinson, and M. A. Norcross. 1992. Analysis of HIV-induced autoantibodies to cryptic epitopes on human CD4. J. Immunol. 149:2194.
24. Durazzo, M., T. Philipp, F. N. Van Pelt, B. Luttig, E. Borghesio, G. Michel, E. Schmidt, S. Loges, M. Rizzetto, and M. P. Manns. 1995. Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection. Gastroenterology 108:455.
25. Wedell, A., and H. Luthman. 1993. Steroid 21-hydroxylase (P450c21): a new allele and spread of mutations through the pseudogene. Hum. Genet. 91:236.
26. Nelson, D. R., and H. W. Strobel. 1988. On the membrane topology of vertebrate cytochrome P-450 proteins. J. Biol. Chem. 263:6038.
27. Black, S. D. 1992. Membrane topology of the mammalian P450 cytochromes. FASEB J. 6:680.
28. Ravinchandran, K. G., S. S. Boddupalli, C. A. Hasermann, J. A. Peterson, and J. Deisenhofer. 1993. Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450s. Science 261:731.